What Your Company Is Worth: A Founder's Guide to EBITDA Multiples in 2026

Ask ten founders how their company should be valued and nine will answer in EBITDA multiples. They are not wrong. For privately held U.S. businesses in the $2 million to $50 million EBITDA range, adjusted EBITDA multiples remain the working shorthand of the M&A market — the number that appears on the term sheet, the number the lender underwrites, and the number the board reports to its investment committee.

But the multiple you see in headlines — 6x, 8x, 10x — hides more than it reveals. Two companies in the same industry, with the same reported EBITDA, routinely trade at spreads of two to three turns. Understanding why is the single most valuable exercise a founder can do before running a process.

Size is the first and largest driver. Below roughly $3 million of EBITDA, the buyer universe is thinner, execution risk is higher, and multiples compress. Between $5 million and $15 million, the private equity mid-market shows up in force. Above $20 million, sponsor competition intensifies and multiples step up again.

Growth trajectory is next. A business growing revenue at 15% per year with expanding margins earns a materially different multiple than a flat business with the same absolute EBITDA. Buyers pay for the forward year, not the trailing one.

Customer concentration, contract quality, and revenue recurrence follow. A recurring-revenue book with net retention above 100% is worth a full turn or more relative to a project-based book of identical size. Concentration above 25% in a single customer typically costs at least a half turn — and often triggers an earn-out.

Finally, quality of management and the depth of the second layer of the team. A business that runs when the founder is on vacation is worth more than a business that does not. This is not sentimentality — it is what determines whether a buyer needs the founder to sign a five-year employment agreement or a twelve-month transition.

The multiple is applied to adjusted EBITDA, and adjusted EBITDA is a construction, not a fact. Every private company has legitimate normalizing adjustments: above-market owner compensation, one-time professional fees, personal expenses, the last cycle's non-recurring losses. Each dollar identified and defended is a dollar multiplied at exit.

The mistake is to build the adjustments after receiving a Letter of Intent, when the buyer's Quality of Earnings team is already engaged. By then, most adjustments look defensive. The discipline is to build a rigorous adjusted EBITDA schedule before going to market — supported by documentation, reviewed by an independent advisor, and pressure-tested against how a QoE firm will read it.

Deal volume in the U.S. middle market recovered meaningfully through late 2025 as debt markets normalized and record levels of private equity dry powder began deploying. Multiples for high-quality assets — recurring revenue, defensible margins, credible growth — have returned to their historical premium. Multiples for average assets remain more disciplined than the 2021 peak, which is a healthier equilibrium for sellers with genuinely good businesses.

For founders considering a transaction in the next twelve to twenty-four months, the practical implication is straightforward: the market is open, the buyers are active, and the work that determines outcome is the preparation done before the process begins.